Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

303

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Prostate Adenocarcinoma

Interventions

RADIATION

Proton Therapy

RADIATION

IMRT

Trial Locations (2)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01352429 - Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer | Biotech Hunter | Biotech Hunter